The future of hospital-at-home amid Medicaid uncertainty

Medicare has granted waivers to 256 hospitals in 37 states to conduct hospital-at-home programs, but uncertainty over Medicare’s future involvement has been hindering these programs from being adopted more widely, The New York Times reported Nov. 19. 

Advertisement

In November 2020, Medicare officials said that while the public health emergency continued, hospitals could apply for a waiver of certain reimbursement requirements, including 24/7 on-site nursing care. 

Hospitals whose applications were approved would receive the same payment for hospital-at-home care as for in-hospital care.

This allowed hospital-at-home programs, which initially focused on treating acute illnesses like pneumonia, urinary tract infections and heart failure, to advance and treat patients for postsurgical care and cancer.

But Medicare’s waivers are not permanent, and the public health emergency is set to end in January. This has caused uncertainty around whether hospitals and health systems can keep these programs alive without the waiver. 

According to a poll by the Hospital at Home Users Group, many of the groups said they were unlikely to keep offering the option if the waiver ends. Forty percent said they were unsure, and 33 percent said their programs were likely to continue.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

What clinicians need from AI after the pilot: Lessons from Adventist Health and Rady Children’s

Friday, July 24
12:00 PM - 1:00 PM CDT

Presenters: Dr. Dieter Sumerauer, Rady Children’s HealthDr. Salman Naqvi, AdventistDr. Reid Conant, Abridge

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.